GlassScriptPhysician profile
Yardana Gill
NPI 1154789154
$1,850.74
in general payments reported to CMS, 2019-2025
21 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $715 · 2022: $605 · 2023: $232 · 2024: $189 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $531.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $373.38 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Janssen Pharmaceuticals, INC | $221.32 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $206.22 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $185.04 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $148.86 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $141.39 | 2021-2024 | Wainua |
| Amgen INC. | $107.50 | 2022-2024 | Repatha |
| Tactile Systems Technology INC | $59.75 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| E.R. Squibb & Sons, L.L.C. | $47.94 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $46.13 | 2022 | |
| Pfizer INC. | $44.45 | 2022-2023 | |
| Daiichi Sankyo INC. | $39.64 | 2023-2024 | Injectafer |
| Cathworks, INC. | $37.90 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $33.94 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $32.70 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.36 | 2021-2025 | Lifevest |
| Janssen Scientific Affairs, LLC | $25.71 | 2022 | |
| Boston Scientific Corporation | $19.30 | 2023 | Bodyguardian |
| Astellas Pharma US INC | $18.16 | 2021 | |
| Esperion Therapeutics, INC. | $15.37 | 2021 | |
| Atricure, INC. | $13.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yardana Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.